DITROPAN Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Ditropan, and when can generic versions of Ditropan launch?
Ditropan is a drug marketed by Ortho Mcneil Janssen and Janssen Pharms and is included in three NDAs.
The generic ingredient in DITROPAN is oxybutynin chloride. There are sixteen drug master file entries for this compound. Thirty-nine suppliers are listed for this compound. Additional details are available on the oxybutynin chloride profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Ditropan
A generic version of DITROPAN was approved as oxybutynin chloride by TEVA PHARMS USA on November 14th, 1988.
Summary for DITROPAN
| US Patents: | 0 |
| Applicants: | 2 |
| NDAs: | 3 |
| Raw Ingredient (Bulk) Api Vendors: | 89 |
| Clinical Trials: | 21 |
| Patent Applications: | 3,958 |
| Formulation / Manufacturing: | see details |
| Drug Prices: | Drug price information for DITROPAN |
| What excipients (inactive ingredients) are in DITROPAN? | DITROPAN excipients list |
| DailyMed Link: | DITROPAN at DailyMed |
Recent Clinical Trials for DITROPAN
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Brigham and Women's Hospital | Phase 2 |
| Kessler Foundation | Phase 2 |
| National Institute on Disability, Independent Living, and Rehabilitation Research | Phase 2 |
Anatomical Therapeutic Chemical (ATC) Classes for DITROPAN
US Patents and Regulatory Information for DITROPAN
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Ortho Mcneil Janssen | DITROPAN | oxybutynin chloride | SYRUP;ORAL | 018211-001 | Approved Prior to Jan 1, 1982 | DISCN | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
| Janssen Pharms | DITROPAN XL | oxybutynin chloride | TABLET, EXTENDED RELEASE;ORAL | 020897-002 | Dec 16, 1998 | DISCN | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
| Janssen Pharms | DITROPAN | oxybutynin chloride | TABLET;ORAL | 017577-001 | Approved Prior to Jan 1, 1982 | DISCN | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
